ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,070,131 | +4.3% | 14,381 | -17.3% | 0.01% | +10.0% |
| Q2 2023 | $6,777,405 | +4.6% | 17,390 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $6,479,166 | -1.6% | 17,390 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $6,587,854 | +11.2% | 17,390 | +3.6% | 0.01% | 0.0% |
| Q3 2022 | $5,926,000 | -4.5% | 16,784 | +2.5% | 0.01% | +11.1% |
| Q2 2022 | $6,203,000 | -26.4% | 16,373 | -39.1% | 0.01% | -18.2% |
| Q1 2022 | $8,424,000 | +27.3% | 26,873 | +42.3% | 0.01% | +22.2% |
| Q4 2021 | $6,615,000 | +41.2% | 18,889 | +21.8% | 0.01% | +28.6% |
| Q3 2021 | $4,685,000 | +7.8% | 15,513 | +7.4% | 0.01% | +40.0% |
| Q2 2021 | $4,347,000 | +18.0% | 14,440 | +8.0% | 0.01% | 0.0% |
| Q1 2021 | $3,683,000 | -56.6% | 13,373 | -53.7% | 0.01% | -16.7% |
| Q4 2020 | $8,486,000 | +87.1% | 28,854 | +66.9% | 0.01% | -14.3% |
| Q3 2020 | $4,536,000 | +27.5% | 17,292 | +9.5% | 0.01% | +16.7% |
| Q2 2020 | $3,558,000 | +146.2% | 15,796 | +49.7% | 0.01% | +100.0% |
| Q1 2020 | $1,445,000 | -14.4% | 10,551 | +0.3% | 0.00% | 0.0% |
| Q4 2019 | $1,688,000 | +8.0% | 10,517 | -23.7% | 0.00% | 0.0% |
| Q3 2019 | $1,563,000 | -17.8% | 13,791 | +2.7% | 0.00% | 0.0% |
| Q2 2019 | $1,902,000 | +13.4% | 13,434 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,677,000 | – | 13,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |